These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 2011158)

  • 21. Are heterocygotes for classical homocystinuria at risk of vitamin B12 and folic acid deficiency?
    Elsaid MF; Bener A; Lindner M; Alzyoud M; Shahbek N; Abdelrahman MO; Abdoh G; Bessisso MS; Zschocke J; Hoffmann GF
    Mol Genet Metab; 2007; 92(1-2):100-3. PubMed ID: 17686644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A hyperhomocysteinemia study in a population with a familial factor for acute myocardial infarct and sudden cardiac death at a young age].
    Bollani G; Ferrari R; Bersatti F; Ferrari M; Cattaneo M; Zighetti ML; Visioli O; Assanelli D
    Cardiologia; 1999 Jan; 44(1):75-81. PubMed ID: 10188334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia.
    Clarke R; Naughten E; Cahalane S; Sullivan KO; Mathias P; McCall T; Graham I
    Ir J Med Sci; 1992 Sep; 161(9):561-4. PubMed ID: 1428778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine response to methionine challenge in four obligate heterozygotes for homocystinuria and relationship with cystathionine beta-synthase mutations.
    Sperandeo MP; Candito M; Sebastio G; Rolland MO; Turc-Carel C; Giudicelli H; Dellamonica P; Andria G
    J Inherit Metab Dis; 1996; 19(3):351-6. PubMed ID: 8803779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.
    Wilcken DE; Reddy SG; Gupta VJ
    Metabolism; 1983 Apr; 32(4):363-70. PubMed ID: 6684724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
    Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
    FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution.
    Sacco RL; Roberts JK; Jacobs BS
    Neuroepidemiology; 1998; 17(4):167-73. PubMed ID: 9701830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperhomocysteinemia--a risk factor for development of occlusive vascular diseases].
    Milosević-Tosić M; Borota J
    Med Pregl; 2002; 55(9-10):385-91. PubMed ID: 12584890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystathionine beta-synthase polymorphisms and hyperhomocysteinaemia: an association study.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; Den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2003 Jan; 11(1):23-9. PubMed ID: 12529702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice.
    Dayal S; Arning E; Bottiglieri T; Böger RH; Sigmund CD; Faraci FM; Lentz SR
    Stroke; 2004 Aug; 35(8):1957-62. PubMed ID: 15178827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.
    de Franchis R; Fermo I; Mazzola G; Sebastio G; Di Minno G; Coppola A; Andria G; D'Angelo A
    Thromb Haemost; 2000 Oct; 84(4):576-82. PubMed ID: 11057853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma homocysteine in venous thromboembolism.
    Brattström L; Tengborn L; Lagerstedt C; Israelsson B; Hultberg B
    Haemostasis; 1991; 21(1):51-7. PubMed ID: 1864556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic defects as important factors for moderate hyperhomocysteinemia.
    Geisel J; Zimbelmann I; Schorr H; Knapp JP; Bodis M; Hübner U; Herrmann W
    Clin Chem Lab Med; 2001 Aug; 39(8):698-704. PubMed ID: 11592436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.